Key result
Rolofylline facilitates diuresis and preserves renal function in patients with acute decompensated heart failure and renal dysfunction, with pilot data suggesting beneficial effects on symptoms.
Why the study?
Does rolofylline improve outcomes and preserve renal function in patients with acute decompensated heart failure and cardiorenal syndrome?
Does rolofylline improve outcomes and preserve renal function in patients with acute decompensated heart failure and cardiorenal syndrome?
Rolofylline shows potential for facilitating diuresis and preserving renal function in acute decompensated heart failure, but safety concerns regarding seizures require careful patient selection.
Answers are grounded in this paper and cite their sources.
May warrant targeted trials despite seizure risk; leaves open adenosine antagonism in cardiorenal syndrome.
BACKGROUND: Co-existent cardiac and renal dysfunction is increasingly recognized as both a predictor and mediator of poor outcomes in patients with advanced heart failure. Novel therapies, including adenosine receptor antagonists, are currently under development for the treatment of 'cardiorenal syndrome'. OBJECTIVES: To review the pathophysiologic rationale for using rolofylline, a selective adenosine 1 receptor antagonist, in patients with cardiorenal syndrome; and to provide a critical overview of safety and efficacy data from clinical studies. METHODS: We reviewed published data on the pharmacology of rolofylline, and used this to inform a comprehensive summary of preclinical and clinical trials. Cardiac and renal effects, and safety data with a particular reference to seizures, are highlighted. RESULTS/CONCLUSION: Rolofylline facilitates diuresis and preserves renal function in patients with acute decompensated heart failure and renal dysfunction. Pilot data also suggest beneficial effects on symptoms and short-term outcomes. The risk of seizures may be minimized by excluding high-risk patients.
No takes yet. Share an insight, caveat, or question.
Slawsky et al. (2009) conducted a review in Acute decompensated heart failure and renal dysfunction (cardiorenal syndrome). Rolofylline was evaluated. Rolofylline facilitates diuresis and preserves renal function in patients with acute decompensated heart failure and renal dysfunction, with pilot data suggesting beneficial effects on symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: